CLINICAL_TRIALS trial_result · 2025-06-26

Clinical Trial Update: Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas [Phase 1]

Phase 1 trial assessing safety and pharmacokinetics of HMPL-689 in patients with lymphoma was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Hutchmed | Conditions: Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2025-06-26